Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo - Progress, obstacles and challenges in HIV/AIDS health services

Int J Infect Dis. 2018 Dec:77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17.


The HIV epidemic continues to be a major global public health issue. Since 2012, there has been a paucity of information from the Republic of the Congo on HIV incidence and prevalence rates, national HIV programme effectiveness, highly active antiretroviral therapy (HAART) rollout, patient adherence to treatment, operational and basic science research studies on HIV/AIDS, and donor funding and its impact on the country. A review of the existing literature on HIV in the Republic of the Congo was conducted, focused on prevalence trends, effectiveness of the current national HIV programme, HAART rollout, patient adherence to antiretrovirals (ARVs), resistance to ARVs, the cost of treatment, and operational issues affecting HIV/AIDS programmes in the country. In light of the findings, several important priority areas for scaling-up HIV/AIDS services, programmatic and research activities in the Republic of the Congo are highlighted.

Keywords: AIDS; ARV; Coverage; HAART; HIV; Impact; Republic of the Congo; Treatment.

Publication types

  • Review

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Congo / epidemiology
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV Infections / transmission*
  • Health Services
  • Humans
  • Incidence
  • Infectious Disease Transmission, Vertical*
  • Medication Adherence
  • Prevalence
  • Program Evaluation
  • Sustainable Development*
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
  • Viral Load


  • Anti-Retroviral Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination